GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Tonight’s Hot Topic Tuesday revisits injectable weight-loss drugs and the new discoveries coming out about the medications.

Wegovy seems to be more effective for weight loss. Research shows semaglutide can lead to weight loss in a dose-dependent fashion — that is, the higher the dose, the more effective it is.

The science that helped develop weight loss drug Wegovy is leading to other medications that are expected in 2023. These new drugs can reduce weight up to 20%, though doctors caution that not ...

Wegovy weight loss drug has heart benefits, study found 00:23 (CNN) - Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss ...

In addition, nearly 32% of people taking Zepbound lost at least a quarter of their body weight, compared to about 16% of those taking Wegovy, the study found. Weight loss was about 6% lower in men ...